Analysts Set Bath & Body Works, Inc. (NYSE:BBWI) Target Price at $43.19

Bath & Body Works, Inc. (NYSE:BBWI) has been assigned a consensus rating of “Moderate Buy” from the seventeen ratings firms that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and ten have issued a buy rating on the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $43.19.

Several analysts recently commented on the stock. Telsey Advisory Group reaffirmed an “outperform” rating and set a $42.00 target price on shares of Bath & Body Works in a report on Monday, November 25th. TD Cowen upped their target price on Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research report on Thursday, December 12th. Wells Fargo & Company raised Bath & Body Works from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $42.00 to $48.00 in a report on Friday, January 10th. Morgan Stanley reduced their price target on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research note on Thursday, November 21st. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th.

Bath & Body Works Stock Up 1.2 %

NYSE:BBWI opened at $36.46 on Friday. Bath & Body Works has a 12-month low of $26.20 and a 12-month high of $52.99. The firm has a market capitalization of $7.90 billion, a price-to-earnings ratio of 8.89, a P/E/G ratio of 0.90 and a beta of 1.83. The stock’s 50 day moving average price is $37.63 and its two-hundred day moving average price is $33.69.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.46 by $0.03. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business had revenue of $1.61 billion for the quarter, compared to analysts’ expectations of $1.58 billion. During the same quarter in the prior year, the business earned $0.48 EPS. The firm’s revenue for the quarter was up 3.1% on a year-over-year basis. Equities research analysts expect that Bath & Body Works will post 3.26 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, March 7th. Stockholders of record on Friday, February 21st will be issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.19%. The ex-dividend date is Friday, February 21st. Bath & Body Works’s dividend payout ratio (DPR) is presently 19.51%.

Institutional Trading of Bath & Body Works

Several large investors have recently made changes to their positions in the company. Golden State Wealth Management LLC bought a new position in Bath & Body Works in the fourth quarter valued at about $26,000. SRS Capital Advisors Inc. boosted its stake in shares of Bath & Body Works by 99.7% in the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock valued at $26,000 after purchasing an additional 329 shares in the last quarter. True Wealth Design LLC grew its holdings in shares of Bath & Body Works by 5,270.0% during the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock valued at $34,000 after purchasing an additional 1,054 shares during the last quarter. UMB Bank n.a. increased its position in Bath & Body Works by 58.8% during the 4th quarter. UMB Bank n.a. now owns 905 shares of the company’s stock worth $35,000 after purchasing an additional 335 shares in the last quarter. Finally, Lindbrook Capital LLC increased its position in Bath & Body Works by 81.9% during the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock worth $37,000 after purchasing an additional 431 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.